The WATCHMAN Left Atrial Appendage Closure Device is a first-of-its-kind, proven alternative to commonly-used blood thinner warfarin to prevent stoke in patients with atrial fibrillation or an abnormal heart beat. The WATCHMAN device is implanted into the heart to close off the left atrial appendage (LAA), a blind pouch of heart tissue where blood clots can form and then break off and travel in the blood stream to the brain and cause strokes. The device is inserted into the heart through a catheter placed into a vein in the leg during a one-time, minimally invasive procedure in a cardiac catheterization lab. By closing off the LAA, patient’s risk of stroke is reduced and it may probably over time allow them to stop taking warfarin.
Beaumont cardiologists performed the Midwest’s first commercial implant of the WATCHMAN device in March 2015. To make an appointment with a Beaumont cardiologist, call 800-633-7377.